The Biologics Safety Testing Market Share is poised to witness a CAGR of 9.3% between 2022, reaching US$ 4,360 Million. With the ever-increasing population suffering from chronic ailments, the...
The Neuroscience Market Share is expected to reach US$ 520 Million between 2025 at a CAGR of 7.2%. Speedy development on the part of ICT does bring in new-fangled advantages like more autonomy...
The Gene Expression Analysis Market Share is expected to be worth US$ 1,200 Million at a CAGR of 6% between 2022. The present scenario is such that the patients’ social and personal resources...
The Non-Invasive Prenatal Testing Nipt Market Share is expected to reach US$ 850 Million between 2024 at a CAGR of 10.2%. Speedy development on the part of ICT does bring in new-fangled advantages...
The Life Science Market Share is all set to witness a CAGR of 4% and reach US$ 4,200 Million between 2024. The present-day scenario is such that mobile technology has elevated patient care and...
The Microbiome Therapeutic Market Share is expected to witness a CAGR of 62.9% between 2025 (reaching US$ 890 Million). Vertical integration is the latest trend concerning the healthcare...
TheIngestible Smart Pills Market Share is expected to reach US$ 1,000 Million at a CAGR of 7.7% between 2024. With the WHO at the helm of universal health coverage, all the communities across the...
The Duchenne Muscular Dystrophy Treatment Market Share is expected to be worth US$ 9,000 Million at a CAGR of 48.3% from 2026. With remote patient monitoring being the epicenter of healthcare,...
The Gynaecological Cancer Drugs Market Share is slated to reach US$ 13,700 Million between 2026 at a CAGR of 6.2%. The healthcare vertical, on the whole, is moving towards value-based care. In other...
The Oligonucleotide Synthesis Market Share is expected to be worth US$ 540 Million at a CAGR of 13.9% between 2025. The present scenario is such that the patients’ social and personal...